Core Insights - Catheter Precision, Inc. has successfully launched its LockeT suture retention device in Switzerland, marking a significant milestone for the company in the cardiac electrophysiology market [1][2] Company Overview - Catheter Precision is a U.S.-based medical device company focused on developing innovative solutions for the treatment of cardiac arrhythmias, particularly through advancements in electrophysiology procedures [4] Product Launch and Clinical Outcomes - The first clinical cases of the LockeT device were performed at Spitalzentrum Biel, led by PD Dr. Rainer Zbinden, resulting in excellent procedural outcomes and positive feedback from clinical and nursing teams [2] - The LockeT device is designed to assist in wound closure after percutaneous venous punctures and is classified as a Class 1 device registered with the FDA, also having received CE Mark approval [3] Strategic Partnerships - The launch follows a strategic distribution agreement with FuMedica AG, a prominent Swiss medical device distributor, which will facilitate the introduction of LockeT to hospitals and clinics across Switzerland, thereby expanding Catheter Precision's European presence [2][3] Market Growth - Over 10,000 LockeT devices have been shipped globally, indicating rapid growth and the company's commitment to working closely with partners to enhance patient care [3]
Catheter Precision Announces Launch of LockeT in Switzerland